NSN 6505-00-149-3507, 6505001493507
Cancelled -> Replaced by 6505011533148

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 001493507
Codification Country: United States
Item Name Code: INC 45248
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-00-149-3507

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-00-149-3507

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-00-149-3507

National Stock Number (NSN) 6505-00-149-3507, or NIIN 001493507, (bupivacaine and epinephrine inje) was assigned October 27, 1974 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN replaces 1 stock number, 6505011533148.

There are 4 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 4 suppliers. Today, 3 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Sep 13, 2011. There has been one contract issued for this part number, with 2 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPM20007A1002, SPM20007A1002. The total value of the awarded contracts has been US$ 14.82.

There has been very little demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Apr 12, 2014, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 45248. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505001493507 does not contain precious metals.

This information was last updated on Aug 01, 2025.

Technical Characteristics

EXTERIOR CONTAINER WEIGHT: (ECWT) 32.00 POUNDS
EXTERIOR CONTAINER QUANTITY: (EXQT) 100
INTERMEDIATE PACKAGE QUANTITY: (PKQT) 5
UNIT OF ISSUE CUBE: (SUCB) 0.0062 CUBIC FEET
EXTERIOR CONTAINER CUBIC MEASURE: (EXME) 0.62 CUBIC FEET
III SUPPLEMENTARY FEATURES: (SUPP) MULTIPLE-DOSE VIAL
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 0.500 PERCENTAGE, W/V BUPIVACAINE HYDROCHLORIDE ACTIVE INGREDIENT AND 0.0005 PERCENTAGE, W/V EPINEPHRINE ACTIVE INGREDIENT
ADMINISTRATION: (CSGS) NERVE BLOCK
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) BUPIVACAINE AND EPINEPHRINE INJECTION USP 50ML BT
MEDICAL DESIGNATION AND GRADE: (MDES) UNITED STATES PHARMACOPEIA
SPECIAL FEATURES: (FEAT) 0.5 % BUPIVICAINE HYDROCHLORIDE AND 0.0005% EPINEPHRINE ACTIVE INGREDIENTS; 50 ML BOTTLE; SUBJECT TO DAMAGE BY FREEZING; FOR USE IN CAUDAL, EPIDURAL, OR PERIPHERAL NERVE BLOCK
PHARMACEUTICAL VEHICLE TYPE: (AKJQ) AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: (CQCT) BOTTLE,MULTIPLE DOSE
SUPPLEMENTARY FEATURES: (SUPP) MULTIPLE-DOSE VIAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) BUPIVACAINE AND EPINEPHRINE INJECTION USP 50ML BT
MEDICAL DESIGNATION: (MDES) UNITED STATES PHARMACOPEIA
SPECIAL FEATURES: (FEAT) SUITABLE FOR CAUDAL,EPIDURAL,OR PERIPHERAL NERVE BLOCK
PROTECTIVE STORAGE FEATURE: (AJCN) SUBJECT TO DAMAGE BY FREEZING